Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capillary Permeability | 9 | 2011 | 132 | 1.060 |
Why?
|
| Atrial Natriuretic Factor | 4 | 2011 | 39 | 0.890 |
Why?
|
| Endothelial Cells | 8 | 2013 | 464 | 0.780 |
Why?
|
| Lung | 8 | 2013 | 1292 | 0.770 |
Why?
|
| Lipopolysaccharides | 5 | 2013 | 295 | 0.770 |
Why?
|
| Endothelium, Vascular | 5 | 2013 | 435 | 0.550 |
Why?
|
| rho-Associated Kinases | 3 | 2013 | 160 | 0.420 |
Why?
|
| Pulmonary Artery | 3 | 2011 | 323 | 0.410 |
Why?
|
| Lung Injury | 2 | 2013 | 53 | 0.400 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2011 | 4 | 0.390 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 272 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2011 | 700 | 0.350 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 64 | 0.340 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 153 | 0.320 |
Why?
|
| Ventilator-Induced Lung Injury | 4 | 2010 | 31 | 0.280 |
Why?
|
| Signal Transduction | 6 | 2013 | 3406 | 0.240 |
Why?
|
| Electric Impedance | 3 | 2011 | 111 | 0.200 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2011 | 323 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 8 | 2011 | 3257 | 0.190 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2010 | 73 | 0.190 |
Why?
|
| Cells, Cultured | 6 | 2013 | 2887 | 0.180 |
Why?
|
| Iloprost | 2 | 2010 | 15 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 128 | 0.140 |
Why?
|
| Mice | 9 | 2011 | 11869 | 0.120 |
Why?
|
| Time Factors | 4 | 2011 | 5362 | 0.120 |
Why?
|
| Receptor Cross-Talk | 1 | 2013 | 33 | 0.110 |
Why?
|
| Cytoskeleton | 2 | 2011 | 195 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 125 | 0.100 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2010 | 55 | 0.100 |
Why?
|
| Hormone Antagonists | 1 | 2011 | 19 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2009 | 696 | 0.090 |
Why?
|
| p21-Activated Kinases | 1 | 2010 | 16 | 0.090 |
Why?
|
| Animals | 10 | 2011 | 27551 | 0.090 |
Why?
|
| Inflammation | 3 | 2013 | 982 | 0.090 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2009 | 8 | 0.090 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2009 | 42 | 0.090 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2009 | 25 | 0.090 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2009 | 13 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 278 | 0.080 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 54 | 0.080 |
Why?
|
| Adherens Junctions | 1 | 2009 | 34 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 885 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 2395 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 108 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 2009 | 49 | 0.080 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2009 | 37 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 996 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 54 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2009 | 277 | 0.080 |
Why?
|
| Cadherins | 1 | 2009 | 163 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2010 | 2017 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 226 | 0.080 |
Why?
|
| Amifostine | 1 | 2008 | 51 | 0.080 |
Why?
|
| Mechanoreceptors | 1 | 2008 | 36 | 0.080 |
Why?
|
| Radiation-Protective Agents | 1 | 2008 | 98 | 0.080 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2008 | 84 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2009 | 466 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 341 | 0.070 |
Why?
|
| RNA, Small Interfering | 4 | 2009 | 557 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2009 | 1130 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2009 | 358 | 0.070 |
Why?
|
| Male | 9 | 2011 | 42705 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1929 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 405 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2009 | 469 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2026 | 0.060 |
Why?
|
| Humans | 10 | 2013 | 90014 | 0.060 |
Why?
|
| Thrombin | 2 | 2010 | 61 | 0.040 |
Why?
|
| Random Allocation | 2 | 2010 | 327 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2009 | 48 | 0.040 |
Why?
|
| Oligopeptides | 2 | 2010 | 188 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2010 | 8295 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2013 | 18 | 0.030 |
Why?
|
| Peptidoglycan | 1 | 2013 | 31 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2010 | 16 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2009 | 13 | 0.020 |
Why?
|
| Microtubules | 1 | 2010 | 123 | 0.020 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 178 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 253 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 247 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 120 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2010 | 474 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2008 | 74 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 378 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 793 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 388 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 376 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 899 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 200 | 0.020 |
Why?
|
| Antioxidants | 1 | 2008 | 226 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2008 | 264 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 490 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2495 | 0.020 |
Why?
|
| Actins | 1 | 2008 | 462 | 0.020 |
Why?
|